Nov 23, 2022
Kenneth Anderson, M.D., holds the Kraft Family Professor of Medicine and is the Director of Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at Dana-Farber Cancer Institute. He has conducted research on multiple myeloma for over four decades and his work has led to clinical trials that culminated in new FDA-approved targeted therapies. He is the past President of the International Myeloma Society and the American Society of Hematology and is a recipient of many scientific and humanitarian awards including the Giants of Cancer Care and the American Association for Cancer Research Joseph H. Burchenal Award amongst many others.
“Treat patients as family and make science count for patients - if you do these two things, all the rest of the details will fall into place.” Tune into a conversation with Dr. Kenneth Anderson on his journey to developing therapies that have transformed care for patients with multiple myeloma - highlighting the importance of maintaining focus while keeping an open mind, recognizing the power of teamwork, and always keeping the patient at the center of your research.